Axentri Tablet (Maraviroc)
Axentri Tablet belongs to a group of medicines called CCR5 antagonists. It is used to treat HIV (human immunodeficiency virus), the virus that can cause AIDS (acquired immunodeficiency syndrome). It prevents the entry of HIV virus into the human body and thus controls the infection.
Uses of Axentri Tablet
- HIV infection
Benefits of Axentri Tablet
Axentri 150mg Tablet prevents HIV from multiplying in the body. It helps control the infection and make the immune system work better. This lowers the chances of getting complications, such as new infections, and improves the quality of life. This medicine is always taken in combination with other antiretroviral medicines.
It is not a cure of HIV or AIDS and should not be used to prevent HIV after accidental exposure to a risk. It is important to take this medicine as prescribed by the doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of this combination of medicines and reduces the chances of HIV infection becoming resistant to antiretroviral medicines. Although taking this medicine does not prevent the passing of HIV to other people.
Side effects of Axentri Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Common side effects of Axentri
- Nausea
- Rash
- Anemia (low number of red blood cells)
- Insomnia (difficulty in sleeping)
- Weakness
- Increased liver enzymes
- Abdominal pain
- Flatulence
- Loss of appetite
- Depression
How to use Axentri Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Axentri 150mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
How Axentri Tablet works
Axentri 150mg Tablet is a chemokine receptor antagonist. It shows its action by binding to the human chemokine receptor CCR5 present on the membrane of CD4 cells (T-cells) and prevents the interaction of HIV with CCR5 required by the HIV virus to enter the human cells.
